# Lantus

NDC: 50090-0876
Generic name: insulin glargine
Labeler / Manufacturer: A-S Medication Solutions
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20090923

FDA application: BLA021081

## Active ingredients

- INSULIN GLARGINE: 100 [iU]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50090-0876"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50090-0876
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ae27bb66-5dbe-4f01-a89e-f4fa7cb09c99